361 related articles for article (PubMed ID: 9581743)
1. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
Stambler BS; Wood MA; Ellenbogen KA
Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Stambler BS; Wood MA; Ellenbogen KA
Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
[TBL] [Abstract][Full Text] [Related]
7. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
[TBL] [Abstract][Full Text] [Related]
8. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
Varriale P; Sedighi A
Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074
[TBL] [Abstract][Full Text] [Related]
9. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.
Foster RH; Wilde MI; Markham A
Drugs; 1997 Aug; 54(2):312-30. PubMed ID: 9257085
[TBL] [Abstract][Full Text] [Related]
10. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
11. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
[TBL] [Abstract][Full Text] [Related]
12. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators.
Abi-Mansour P; Carberry PA; McCowan RJ; Henthorn RW; Dunn GH; Perry KT
Am Heart J; 1998 Oct; 136(4 Pt 1):632-42. PubMed ID: 9778066
[TBL] [Abstract][Full Text] [Related]
13. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR
Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596
[TBL] [Abstract][Full Text] [Related]
15. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
[TBL] [Abstract][Full Text] [Related]
16. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
17. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
[TBL] [Abstract][Full Text] [Related]
18. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
20. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.
Delle Karth G; Schillinger M; Geppert A; Haumer M; Gwechenberger M; Meyer B; Heinz G; Siostrzonek P
Wien Klin Wochenschr; 2005 Feb; 117(3):92-7. PubMed ID: 15773423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
